Polymer nanoparticles from low-energy nanoemulsions for biomedical applications

• Santiago Grijalvo and
• Carlos Rodriguez-Abreu

Beilstein J. Nanotechnol. 2023, 14, 339–350, doi:10.3762/bjnano.14.29

• and cell viabilities higher than 75% (for concentrations below 100 nM). These nanoparticles displayed high gene silencing efficiencies (up to 90%) targeting Renilla luciferase mRNA, particularly when coated with PEG (Figure 3) and did not show hemolysis after incubation with red blood cells. PLGA

Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer

• Filip Gorachinov,
• Fatima Mraiche,
• Diala Alhaj Moustafa,
• Ola Hishari,
• Yomna Ismail,
• Jensa Joseph,
• Maja Simonoska Crcarevska,
• Marija Glavas Dodov,
• Nikola Geskovski and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23

• release are crucial to maximize the delivery or co-delivery of active agents to the site of action in the cell [141]. State-of-the-art LNPs for siRNA gene silencing, that is, stable antisense–lipid particles (SALPs) and stable nucleic acid–lipid particles (SNALPs), were recently developed as PEGylated

• lipid carriers based on ionizable lipids with pKa values between 6 and 7. OnpattroTM is the first RNAi therapy used for liver-based gene silencing approved by the FDA and EC and is a SNALP transfection system based on transient PEGylation. The lipid components of these benchmark LNPs for siRNA and mRNA

Cyclodextrins as eminent constituents in nanoarchitectonics for drug delivery systems

• Makoto Komiyama

Beilstein J. Nanotechnol. 2023, 14, 218–232, doi:10.3762/bjnano.14.21

• S–S linkages by intracellular glutathione (GSH). As the result, both gene editing by sgRNA/Cas9 and gene silencing by the antisense DNA cooperatively suppressed the PLK1 gene, providing remarkable antitumor activity. 4 CyD-based nanoarchitectures for effective photodynamic therapy Photodynamic

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

• Nikola Geskovski,
• Nadica Matevska-Geshkovska,
• Simona Dimchevska Sazdovska,
• Marija Glavas Dodov,
• Kristina Mladenovska and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

• -delivery of siRNA and IM for specifically silencing the BCR-ABL oncogene. In this case, IM enables the pre-sensitization of tumor cells, as a prerequisite for effective gene silencing, mediated by the siRNA. The results demonstrate that the siRNA/IM ratio affected the efficacy in BCR-ABL silencing and

Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes

• Alfredo Nuñez-Rivera,
• Pierrick G. J. Fournier,
• Danna L. Arellano,
• Ana G. Rodriguez-Hernandez,
• Rafael Vazquez-Duhalt and
• Ruben D. Cadena-Nava

Beilstein J. Nanotechnol. 2020, 11, 372–382, doi:10.3762/bjnano.11.28

• ) without packaging signal. The gene silencing was demonstrated by VLPs loaded with siGFP and tested on breast tumor cells that constitutively express the green fluorescent protein (GPF). After VLP-siGFP treatment, GFP expression was efficiently inhibited corroborating the cargo release inside tumor cells

• and the gene silencing. In addition, BMV VLP carring siAkt1 inhibited the tumor growth in mice. These results show the attractive potential of plant virus VLPs to deliver molecular therapy to tumor cells with low immunogenic response. Keywords: anti-cancer therapy; brome mosaic virus (BMV); cowpea

• modified chemically and genetically for potential therapeutic applications [30]. Despite these interesting properties, to our knowledge, the use of BMV VLPs for molecular cancer therapies, especially in delivering siRNA for gene silencing, has been scarcely explored. In this work, important BMV VLPs

Poly(1-vinylimidazole) polyplexes as novel therapeutic gene carriers for lung cancer therapy

• Gayathri Kandasamy,
• Elena N. Danilovtseva,
• Vadim V. Annenkov and
• Uma Maheswari Krishnan

Beilstein J. Nanotechnol. 2020, 11, 354–369, doi:10.3762/bjnano.11.26

• that have been connected to the proliferation and invasion of lung cancer cells. These results indicate that the PVI complexes can be an effective agent to counter lung cancer. Keywords: anti-VEGF siRNA; gene silencing; lung cancer; microarray; poly(1-vinylimidazole); small interfering RNA (siRNA

• cells were stained with Hoechst 33258 and imaged with laser scanning confocal microscopy (Olympus FV1000, Tokyo, Japan). Gene expression analysis: VEGF gene silencing was determined using reverse transcriptase-polymerase chain reaction (RT-PCR, AG22331, Eppendorf, Germany). About 3 × 105 A549 cells were

• polyplex) containing a final concentration of 100 nM siRNA and incubated for specified periods of time. The cells were imaged using an inverted microscope to observe the effect of the treatment on the tubular network. Migration analysis Wound healing assay: To evaluate the gene silencing effect of the

Molecular architectonics of DNA for functional nanoarchitectures

• Debasis Ghosh,
• Lakshmi P. Datta and
• Thimmaiah Govindaraju

Beilstein J. Nanotechnol. 2020, 11, 124–140, doi:10.3762/bjnano.11.11

• siRNA-loaded tetrahedrons at the tumor surface 25 min after injection. The siRNA-mediated gene silencing feature was monitored by performing an in vivo firefly luciferase gene expression analysis. The remarkable feature of this study was the one-step synthesis of hybrid DNA–siRNA tetrahedron

Internalization mechanisms of cell-penetrating peptides

• Ivana Ruseska and
• Andreas Zimmer

Beilstein J. Nanotechnol. 2020, 11, 101–123, doi:10.3762/bjnano.11.10

Tungsten disulfide-based nanocomposites for photothermal therapy

• Tzuriel Levin,
• Hagit Sade,
• Rina Ben-Shabbat Binyamini,
• Maayan Pour,
• Iftach Nachman and
• Jean-Paul Lellouche

Beilstein J. Nanotechnol. 2019, 10, 811–822, doi:10.3762/bjnano.10.81

• effect, other ligands on the cerium ion can be replaced by different polymers and linkers. The resulting nanocomposites can be used for biomedical applications, such as gene silencing [52], magnetic imaging, and drug delivery. Here we present a new and simple-to-fabricate WS2-NT-CAN-mag (WS2-NT-CM

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• subcellular localizations [42][82]. There are many cytotoxic drugs, such as doxorubicin, that induce cell apoptosis through intercalation with nuclear DNA. Further, gene silencing therapies based on an effective delivery of short hairpin RNA (shRNA) bearing genes for small interfering RNA (siRNA) need nuclear

Uptake of the proteins HTRA1 and HTRA2 by cells mediated by calcium phosphate nanoparticles

• Olga Rotan,
• Katharina N. Severin,
• Simon Pöpsel,
• Alexander Peetsch,
• Melisa Merdanovic,
• Michael Ehrmann and
• Matthias Epple

Beilstein J. Nanotechnol. 2017, 8, 381–393, doi:10.3762/bjnano.8.40

• ]. For instance, nucleic acids like DNA [10][11][12][13], siRNA [14][15][16][17] and µRNA [18] have been successfully introduced to perform transfection, gene silencing, prophylactic and therapeutic vaccination [19][20][21]. All kinds of synthetic molecules and biomolecules can be transported across the

Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms

• Bin Song,
• Yanli Zhang,
• Jia Liu,
• Xiaoli Feng,
• Ting Zhou and
• Longquan Shao

Beilstein J. Nanotechnol. 2016, 7, 645–654, doi:10.3762/bjnano.7.57

• sites [84][85]. In most cases, DNA methylation not only induces gene silencing [86], but also is related to the initiation of DNA replication [87], DNA mismatch repair [88] and inactivation of transposons [89]. Recently, more and more studies have discovered that CNS dysfunction may be potentially